Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > New corporate presentation is on the website

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Apr 16, 2021 10:15am

62 Views

Post# 33010347

RE:RE:New corporate presentation is on the website

Unfortunately, you are likely on her ignore list by now, maybe some flowers with a nice motivational note would get her attention.

scarlet1967 wrote: Well many people here said they should start the presentation with the R&D programs long time ago, they should be a head of everyone else anyways I forwarded the NT article posted by Wino and my own post re risk adjusted NVP.
One of these days she will give in.

SPCEO1 wrote: Leading with oncology now.